3576
T. Itoh, T. Mase / Tetrahedron Letters 46 (2005) 3573–3577
pyrimidine-H), 7.45 (d, J = 5.5 Hz, 1H, Ar–H), 7.33 (s,
2H, NH2); 13C NMR (125 MHz, DMSO-d6): d 159.07,
159.02, 153.94, 153.85, 145.89, 143.85, 139.97, 139.82,
137.70, 130.20; HRMS calcd for C10H8FN3 (M++H),
190.0780. Found, 190.0805.
6.46 (dd, J = 2.1, 5.5 Hz, 1H, pyridine-H), 6.05
(s, 2H, NH2); 13C NMR (125 MHz, DMSO-d6) d
156.09, 155.01, 149.39, 139.68, 128.35, 128.26, 126.08,
107.76, 104.88; HRMS calcd for C11H10N2 (M++H),
171.0922. Found, 171.1002.
1
Compound 6: crystallized from i-PrOAc/n-heptane. H
1
Compound 4c: crystallized from i-PrOAc/n-heptane. H
NMR (500 MHz, CDCl3): d 8.18 (d, J = 8.9 Hz, 1H,
Ar–H), 7.57 (d, J = 7.7, 8.8 Hz, 2H, Ar–H), 7.18–7.40
(m, 3H, Ar–H), 6.98 (d, J = 1.9 Hz, 1H, Ar–H), 6.93
(dd, J = 1.9, 8.9 Hz, 1H, Ar–H), 6.15 (s, 2H, NH2);
13C NMR (125 MHz, CDCl3): d 148.57, 144.87,
138.93, 131.44, 128.98, 128.89, 127.17, 126.85, 116.55,
116.41; HRMS calcd for C12H10N2O2 (M++H),
215.0821. Found, 215.0829.
NMR (500 MHz, DMSO-d6): d 8.36 (d, J = 7.1 Hz, 2H,
Ar–H), 8.35 (br s, 2H, NH2), 7.59 (dd, J = 7.0, 7.4 Hz,
1H, Ar–H), 7.54 (dd, J = 7.0, 7.4 Hz, 2H, Ar–H), 4.12
(s, 3H, OMe); 13C NMR (125 MHz, DMSO-d6): d
164.02, 162.98, 158.87, 136.07, 132.32, 128.96, 128.90,
114.26, 55.21; HRMS calcd for C11H10N4O3 (M++H),
247.0831. Found, 247.0857.
i
1
Compound 4d: crystallized from PrOAc/n-heptane. H
NMR (500 MHz, CDCl3) d 8.45 (d, J = 8.8 Hz, 1H,
Ar–H), 8.44 (d, J = 7.9 Hz, 1H, Ar–H), 7.50–7.42 (m,
3H, Ar–H), 7.31 (s, 1H, quinazoline-H), 6.92 (s, 1H, quin-
azoline-H), 5.56 (s, 3H, OMe), 4.02 (s, 3H, OMe); 13C
NMR (125 MHz, CDCl3): d 160.12, 159.82, 155.01,
148.95, 148.40, 138.75, 129.81, 128.38, 128.02, 107.95,
106.92, 100.21, 56.27, 56.16; HRMS calcd for
C10H11N3O2 (M++H), 282.1243. Found, 282.1238.
Acknowledgements
Dr. M. Palucki and Dr. N. Yasuda, Merck & Co., Inc.,
are acknowledged for critical reading of this manuscript.
We thank Mr. M. Ishikawa for HRMS analysis.
References and notes
1
1. (a) Criscione, L.; de Gasparo, M.; Buhlmayer, P.; White-
bread, S.; Ramjoue, H. P.; Wood, J. Br. J. Pharmacol.
1993, 110, 761–771; (b) Markham, A.; Goa, K. L. Drugs
1997, 54, 299; (c) Capdeville, R.; Buchdunger, E.;
Zimmermann, J.; Matter, A. Nat. Rev. Drug Discovery
2002, 1, 493–502; (d) Boren, J.; Cascante, M.; Marin, S.;
Comin-Anduix, B.; Centelles, J. J.; Lim, S.; Bassilian, S.;
Ahmed, S.; Lee, W. N.; Boros, L. G. J. Biol. Chem. 2001,
276, 37747.
Compound 4e: H NMR (500 MHz, CDCl3): d 8.16–
8.13 (m, 1H), 7.71–7.67 (m, 2H), 7.53–7.28 (m, 3H),
7.11–7.02 (m, 2H), 3.84 (br s, 2H, NH2); 13C NMR
(125 MHz, CDCl3): d 145.43, 140.44, 140.33, 139.05,
129.20, 128.86, 128.62, 123.45, 123.06; HRMS calcd
for C11H10N2 (M++H), 171.0922. Found, 171.0938.
1
Compound 4f: H NMR (500 MHz, DMSO-d6): d 8.15
´
2. Hassan, J.; Sevignon, M.; Gozzi, C.; Schulz, E.; Lemaire,
M. Chem. Rev. 2002, 102, 1359–1470.
(d, J = 2.7 Hz, 1H, Ar–H), 8.09 (d, J = 9.0 Hz, 1H,
Ar–H), 8.00 (d, J = 3.3 Hz, 1H, Ar–H), 8.00 (d,
J = 7.2 Hz, 1H, Ar–H), 7.74 (dd, J = 2.7 Hz, 1H, Ar–
H), 7.59–7.52 (m, 3H, Ar–H); 13C NMR (125 MHz,
DMSO-d6) d 176.50, 149.92, 138.20, 131.77, 130.43,
129.59, 129.09, 127.03, 126.34, 125.73; HRMS calcd
for C11H10N2 (M++H), 171.0922. Found, 171.0911.
3. (a) Stille, J. K. Angew. Chem., Int. Ed. 1986, 25, 508–524;
(b) Farina, V.; Krishnamurthy, V.; Scott, W. J. Org.
React. 1997, 50, 1; (c) Mitchell, T. N. In Metal-catalyzed
Cross-coupling Reactions; Diedrich, F., Stang, P. J., Eds.;
Wiley-VCH: Weinheim, 1998, p 167.
4. (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457–
2483; (b) Suzuki, A. In Metal-catalyzed Cross-coupling
Reactions; Diedrich, F., Stang, P. J., Eds.; Wiley-VCH:
Weinheim, 1998, p 49; (c) Miyaura, N. Adv. Organomet.
Chem. 1998, 6, 187.
5. (a) Thompson, A. E.; Hughes, G.; Batsanov, A. S.; Bryce,
M. R.; Parry, P. R.; Tarbit, B. J. Org. Chem. 2005, 70,
388–390; (b) Gunda, P.; Russon, L. M.; Lakshman, M. K.
Angew. Chem., Int. Ed. 2004, 43, 6372–6377; (c) Agrofo-
glio, L. A.; Gillaizeau, I.; Saito, Y. Chem. Rev. 2003, 103,
1875–1916; (d) Thompson, W. J.; Jones, J. H.; Lyle, P. A.;
Thies, J. E. J. Org. Chem. 1988, 53, 2052–2055; (e)
Gronowitz, S.; Hoernfeldt, A. B.; Yang, Y. H. Chem.
Chem. Scr. 1986, 26, 311–314.
1
Compound 4g: H NMR (500 MHz, DMSO-d6): d 6.98
(d, J = 8.5 Hz, 1H, Ar–H), 3.50 (br s, 2H, NH2); 13C
NMR (125 MHz, DMSO-d6): d 155.90, 144.33, 131.42,
129.61, 127.55, 112.14, 110.39; HRMS calcd for
C11H10N2 (M++H), 171.0922. Found, 171.0948.
1
Compound 4h: H NMR (500 MHz, CDCl3): d 8.32 (d,
J = 2.4 Hz, 1H, pyridine-H), 7.67 (dd, J = 8.5 Hz, 1H,
pyridine-H), 7.51 (d, J = 8.7 Hz, 1H, Ar–H), 7.50 (d,
J = 7.8 Hz, 1H, Ar–H), 7.43 (d, J = 7.6 Hz, 1H, Ar–
H), 7.41 (d, J = 7.9 Hz, 1H, Ar–H), 7.31 (t, J = 7.4 Hz,
1H, Ar–H), 6.58 (d, J = 8.5 Hz, 1H, pyridine-H), 4.50
(s, 2H, NH2); 13C NMR (125 MHz, CDCl3): d 157.60,
146.43, 138.33, 136.57, 128.90, 127.43, 126.90, 126.30,
108.50; HRMS calcd for C11H10N2 (M++H), 171.0922.
Found, 171.0933.
6. Meier, P.; Legraverant, S.; Muller, S.; Schaub, J. Synthesis
2003, 4, 551–554.
¨
7. Itoh, T.; Sato, K.; Mase, T. Adv. Synth. Catal. 2004, 346,
1859–1867.
8. Sielecki, T. M.; Johnson, T. L.; Liu, J.; Muckelbauer, J.
K.; Grafstrom, R. H.; Cox, S.; Boylan, J.; Burton, C. R.;
Chen, H.; Smallwood, A.; Chang, C.-H.; Boisclair, M.;
Benfield, P. A.; Trainor, G. L.; Seitz, S. P. Bioorg. Med.
Chem. Lett. 2001, 11, 1157–1160.
1
Compound 4i: H NMR (500 MHz, DMSO-d6): d 8.09
(d, J = 5.5 Hz, 1H, pyridine-H), 7.91 (d, J = 8.5 Hz,
1H, Ar–H), 7.91 (d, J = 7.1 Hz, 1H, Ar–H), 7.45–7.36
(m, 3H, Ar–H), 7.00 (d, J = 2.1 Hz, 1H, pyridine-H),
9. Gautheron, C. V.; Ple, M.; Turck, A.; Queguiner, G.
Tetrahedron 2000, 56, 5499–5507.